SCR-LIP-000616 · Claim · machine-readable JSON →
Fibromyalgia is frequently reported to co-occur with lipedema in cross-sectional studies, although reported frequencies vary widely between samples.
General proposition consolidated from 6 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 7 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (7)
- Lipedema awareness in fibromyalgia — Bolkan Günaydın et al. (2025) ✓ verified — consistent · cross sectional · n=100 · 2025 · risk of bias: moderate · reading confidence: high
Among 100 women meeting fibromyalgia criteria, lipedema was found in 50% (58% stage 1); longer fibromyalgia diagnostic delay associated with lipedema.
Gunaydin; lipedema in 50%; pain correlated with widespread pain r=0.62 - Prevalence of Fibromyalgia Syndrome in Women with Lipedema and Its Effect on Anxiety, Depression, and Quality of Life — Cagliyan Turk et al. (2024) ✓ verified — consistent · cross sectional · 2024 · reading confidence: high
“One hundred twenty-four patients (35%) satisfied FMS criteria.”
In an online survey of 354 women with lipedema, 35% (124/354) met ACR 2016 fibromyalgia criteria; those with fibromyalgia had higher anxiety, depression and worse quality of life.
The study directly measures fibromyalgia prevalence in a lipedema population using validated diagnostic criteria (ACR 2016), finding a 35% comorbidity rate. Limitations include self-reported data via online survey and potential selection bi - Common and Contrasting Characteristics of the Chronic Soft-Tissue Pain Conditions Fibromyalgia and Lipedema — Angst et al. (2021) ✓ verified — consistent · cross sectional · 2021 · reading confidence: high
34% of women with lipedema met ACR 2016 criteria for comorbid fibromyalgia; comparison of fibromyalgia and lipedema cohorts showed phenotypic overlap.
Direct empirical comparison of fibromyalgia and lipedema cohorts with validated instruments; cross-sectional design limits causal inference, but the 34% comorbidity rate and phenotypic overlap data directly address the association between l - Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life — ÇAKIT et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
“39,6% (21/53) das pacientes com lipedema preencheram critérios ACR 2016 de FM”
39.6% (21/53) of lipedema patients met ACR 2016 fibromyalgia criteria; the comorbid subgroup had higher pain (median VAS 60 vs 27, p<0.001) and worse SF-36 scores in all domains.
The study directly quantifies the co-occurrence of fibromyalgia in lipedema patients (39.6% met ACR 2016 criteria) and characterizes pain/QoL effects, with results converging with prior studies (34%, 50%). It is observational and unadjusted - Differentiating lipedema and Dercum’s disease — Beltran & Herbst (2017) ✓ verified — refining · cross sectional · 2017 · reading confidence: high
Fibromyalgia was reported in 10% of lipedema patients versus 28% in Dercum's disease (P=0.0003); crude, unadjusted prevalences.
The article documents fibromyalgia, migraines, and pain scores as comorbidities in lipedema patients, providing direct prevalence data bearing on the question. However, prevalences are crude (unadjusted) and the primary focus is differentia - Exploration of Patient Characteristics and Quality of Life in Patients with Lipoedema Using a Survey — Romeijn et al. (2018) ✓ verified — consistent · cross sectional · 2018 · reading confidence: high
In a survey of lipedema patients, fibromyalgia was among the most frequently reported comorbidities (n=14); comorbidities were associated with reduced quality of life.
Cross-sectional survey reports fibromyalgia as a comorbidity and high pain prevalence among lipedema patients, but only crude self-reported counts without adjusted association analysis or control comparison for fibromyalgia specifically. - Lipedema as a Syndrome of Adipose (2026) ✓ verified — contextual · review · 2026 · reading confidence: high
“a 35–40% comorbidity with fibromyalgia, a 1.42 relative risk for ADHD”
A proposed mechanistic framework cites a 35-40% comorbidity of lipedema with fibromyalgia.
Article reports a 35–40% comorbidity of lipedema with fibromyalgia and chronic neuropathic pain features, supporting the affirmative association, though it is a proposed framework/review citing reported observations.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000008